InvestSMART

Acusensus Limited (ASX: ACE) - Announcements

Current share price for ACE : $1.280 0.015 (1.16%)+

ASX company news and announcements for Acusensus Limited (ACE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acusensus Limited (ACE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acusensus Limited (ACE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acusensus Limited (ACE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$219 Acusensus signs introductory road worker safety contract 20 Nov 2024 8:19AM $0.875 $1.280 risen by 46.29%
$219 Q1 FY25 Quarterly Activities Report and Appendix 4C 22 Oct 2024 8:16AM $0.900 $1.280 risen by 42.22%
$219 Acusensus wins tender for WA multi-function contract 21 Oct 2024 8:20AM $0.820 $1.280 risen by 56.10%
$219 2024 Notice of Annual General Meeting 17 Oct 2024 9:25AM $0.840 $1.280 risen by 52.38%
$219 Notification regarding unquoted securities - ACE 17 Sep 2024 9:25AM $0.775 $1.280 risen by 65.16%
$219 Appendix 3Y - Change of Director's Interest Notice 3 Sep 2024 9:21AM $0.690 $1.280 risen by 85.51%
$219 Application for quotation of securities - ACE 3 Sep 2024 9:18AM $0.690 $1.280 risen by 85.51%
$219 Notification of cessation of securities - ACE 3 Sep 2024 9:05AM $0.690 $1.280 risen by 85.51%
$219 Acusensus Corporate Governance Statement and Appendix 4G 27 Aug 2024 8:08AM $0.605 $1.280 risen by 111.57%
$219 Acusensus FY24 Investor Presentation 27 Aug 2024 8:08AM $0.605 $1.280 risen by 111.57%
$219 Acusensus FY24 Results Release 27 Aug 2024 8:08AM $0.605 $1.280 risen by 111.57%
$219 Acusensus Appendix 4E and FY24 Annual Report 27 Aug 2024 8:08AM $0.605 $1.280 risen by 111.57%
$219 Release of Securities from Voluntary Escrow 16 Aug 2024 9:13AM $0.635 $1.280 risen by 101.57%
$219 Acusensus FY24 Results Webinar 29 Jul 2024 8:21AM $0.550 $1.280 risen by 132.73%
$219 Q4 FY24 Quarterly Activities Report and Appendix 4C 24 Jul 2024 8:14AM $0.570 $1.280 risen by 124.56%
$219 Notification of cessation of securities - ACE 2 Jul 2024 5:53PM n/a $1.280 n/a
$219 Appendix 3Y - Change of Director's Interest Notice 20 Jun 2024 8:20AM $0.600 $1.280 risen by 113.33%
$219 Appendix 3Y - Change of Director's Interest Notice 12 Jun 2024 8:35AM $0.550 $1.280 risen by 132.73%
$219 Application for quotation of securities - ACE 31 May 2024 5:56PM $0.615 $1.280 risen by 108.13%
$219 Appendix 3Y - Change of Director's Interest Notices 31 May 2024 5:56PM $0.615 $1.280 risen by 108.13%
$219 Wilsons Conference Presentation and Contracts Update 23 May 2024 8:00AM $0.630 $1.280 risen by 103.17%
$219 Update to Q3 FY24 Quarterly Activities Report 1 May 2024 6:50PM $0.690 $1.280 risen by 85.51%
$219 Q3 FY24 Quarterly Activities Report and Appendix 4C 29 Apr 2024 8:21AM $0.700 $1.280 risen by 82.86%
$219 Q3 FY24 Quarterly Results Webinar 24 Apr 2024 9:53AM $0.685 $1.280 risen by 86.86%
$219 Acusensus Files Proceedings for Patent Infringement 18 Apr 2024 5:21PM $0.690 $1.280 risen by 85.51%

126 - 150 of 353 results

Page 6 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.